Vifor Boosts US Nephrology Prospects With Janssen Pact

Vifor: Selling Invokana In DKD Could Aid Veltassa’s US sales

 
• By Sten Stovall
Kidney_Disease
J&J DKD pact lifts Vifor's nephrology portfolio to 12 products

More from Deals

More from Business